SNX-111: The company modified its clinical trial timeline for SNX-111 by the end of 1997

The company amended the timeline due to difficulties recruiting patients for the malignant pain study, which was to have been completed by the end of 1996. The company plans to complete its pivotal non-malignant pain study within the same time period. ...